StonvexLoading…
StonvexStonvexStonvexCore line items from ORMP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-08-31 |
|---|---|---|---|---|
Revenue | $2.00M | $1.34M | $2.70M | $2.70M |
Operating Income | $-15.09M | $-15.77M | $-40.60M | $-24.22M |
Net Income | $64.05M | $5.09M | $-36.56M | $-22.99M |
EPS (Diluted) | $1.50 | $0.14 | $-0.94 | $0.78 |
Total Assets | $230.86M | $220.55M | $161.64M | $128.00M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $45.95M | $9.05M | $40.46M | $77.25M |
Free Cash Flow OCF − CapEx | $-9.15M | $-10.55M | $-28.41M | $-21.56M |
Shares Outstanding | 39.28M | 40.34M | 39.56M | 35.29M |